Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$4.6 - $5.57 $25.3 Million - $30.7 Million
-5,503,343 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$4.99 - $6.16 $2.88 Million - $3.55 Million
-576,716 Reduced 9.49%
5,503,343 $28.4 Million
Q2 2019

Aug 12, 2019

BUY
$5.92 - $7.41 $44,992 - $56,316
7,600 Added 0.13%
6,080,059 $36.8 Million
Q1 2019

May 09, 2019

BUY
$6.8 - $7.4 $12.3 Million - $13.4 Million
1,814,941 Added 42.63%
6,072,459 $43.9 Million
Q4 2018

Feb 13, 2019

BUY
$3.99 - $7.82 $17 Million - $33.3 Million
4,257,518 New
4,257,518 $31.5 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Alpine Associates Management Inc. Portfolio

Follow Alpine Associates Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Associates Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alpine Associates Management Inc. with notifications on news.